IP Library Granted Patent US 8,460,865
Granted Patent B2
US 8,460,865 · App. 11/739,668 · Granted Jun 11, 2013

Multiplex decoding of array sensors with microspheres

Inventors: Mark S. Chee (Del Mar, CA); John R. Stuelpnagel (Encinitas, CA); Anthony W. Czarnik (San Diego, CA)
Assignee: Illumina, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,460,865
App. No.
11/739,668
Granted
Jun 11, 2013
Kind
B2
Abstract

The invention relates to compositions and methods for multiplex decoding of microsphere array sensors.

Claims (32)

1. A method of decoding an array, said method comprising:

a) providing an array comprising a plurality of bioactive agents randomly distributed at sites of said array, wherein each of a plurality of said sites further comprises at least a first and a second identifier binding ligand (IBL);

b) detecting binding of a first decoder binding ligand (DBL) to the first IBL;

c) detecting binding of a second DBL to the second IBL; and

d) determining the location of the first and second IBLs, thereby decoding the position of one or more bioactive agents on said array; and

wherein said first IBL and said second IBL each comprise different nucleic acid sequences.

2. The method of claim 1 , wherein said array comprises glass or plastic.

3. The method of claim 1 , wherein said array comprises a fiber optic bundle.

4. The method of claim 1 , wherein said array comprises a flat planar surface.

5. The method of claim 4 , wherein said flat planar surface comprises one or more depressions.

6. The method of claim 1 , wherein said plurality of bioactive agents and said first and second IBLs each comprise a nucleic acid.

7. The method of claim 6 , wherein said nucleic acid is selected from the group consisting of DNA and RNA.

8. The method of claim 6 , wherein said nucleic acid is single-stranded.

9. The method of claim 6 , wherein said one of said first and second IBLs comprises substantially the same nucleic acid sequence as one or more bioactive agents.

10. The method of claim 1 , wherein said sites of are divided into a first and a second subpopulation of sites, and wherein said first and second IBLs are attached to said first subpopulation of sites at a first ratio and are attached to said second subpopulation of sites at a second ratio.

11. The method of claim 6 , wherein said nucleic acid is an oligonucleotide of about 8 to about 40 nucleotides in length.

12. The method of claim 1 , wherein said DBL comprises a fluorophore.

13. The method of claim 1 , wherein said sites are regularly arrayed on said array.

14. The method of claim 13 , wherein said regularly arrayed sites are addressable in an X-Y format.

15. The method of claim 1 , wherein said sites are depressions.

16. The method of claim 15 , wherein said depressions are wells.

17. The method of claim 1 , wherein step a) comprises randomly distributing said bioactive agents to an array substrate comprising an etched surface having sites.

18. The method of claim 17 , wherein said sites are wells.

19. The method of claim 6 , wherein said first and second IBLs each comprise a different nucleic acid sequence from said bioactive agents.

20. A method of decoding an array comprising:

a) providing an array comprising a population of microspheres randomly distributed at sites of said array, wherein each microsphere is associated with a bioactive agent, a first identifier binding ligand (IBL), and a second IBL, and wherein said first IBL and said second IBL each comprise a different nucleic acid sequence;

b) detecting binding of a first decoder binding ligand (DBL) to the first IBL;

c) detecting binding of a second DBL to the second IBL; and

d) determining the site having the microsphere comprising the first and second IBLs, thereby decoding the position of one or more bioactive agents on said array.

21. The method of claim 20 , wherein said bioactive agent comprises a nucleic acid that is substantially the same as the first IBL.

22. The method of claim 20 , wherein the bioactive agent comprises a nucleic acid that is different from the first IBL and the second IBL.

23. The method of claim 20 , wherein the array comprises an etched surface.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 25, 2007
From: CHEE, MARK S.; STUELPNAGEL, JOHN R.; CZARNIK, ANTHONY W.
To: ILLUMINA, INC.
Reel/Frame 019217/0391 →
Continuity (12)
Continuation 10187321 · Jun 28, 2002
Continuation In Part 09344526 · Jun 24, 1999
Continuation In Part 09189543 · Nov 10, 1998
Continuation 11285722 · Nov 22, 2005
Continuation In Part 09748706 · Dec 22, 2000
Continuation In Part 09344526
Continuation In Part 09189543
Provisional Application 60302213 · Jun 28, 2001
Provisional Application 60090473 · Jun 24, 1998
Provisional Application 60235531 · Sep 26, 2000
Provisional Application 60172106 · Dec 23, 1999
Related Publication 20070231824A1 · Oct 4, 2007